欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Wnt/Notch/Hedgehog-Hippo-LPi-1
LPi-1

Chemical Structure : LPi-1

CAS No.: 2251130-98-8

LPi-1 (LATS1/2 kinases inhibitor)

货号: PC-25218Not For Human Use, Lab Use Only.

LPi-1 is a highly potent, selective and ATP-competitive inhibitor of large tumor suppressor kinases (LATS1 and LATS2) with IC50 of 4.4 nM and 1.3 nM respectively, abrogates the LATS1/2-mediated YAP1 inhibition in cells, activates YAP1 and its paralogue TAZ in vitro and in vivo.

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

LPi-1 is a highly potent, selective and ATP-competitive inhibitor of large tumor suppressor kinases (LATS1 and LATS2) with IC50 of 4.4 nM and 1.3 nM respectively, abrogates the LATS1/2-mediated YAP1 inhibition in cells, activates YAP1 and its paralogue TAZ in vitro and in vivo.
LPi-1 inhibits LATS1- or LAST2-mediated phosphorylation of YAP1 in a dose-dependent and time-dependent manner.
LPi-1 displaysa high-affinity interaction with the LATS1 and LATS2 proteins, with Kd values of 243.3 and 111.6  nM, respectively, in MST assays.
LPi-1 reduces the phosphorylation of endogenous YAP1 in a dose-dependent manner across various cell lines, including HepG2, HEK293T, Bel7404, HeLa, SNU-423, HCT116, U2OS and primary mouse hepatocytes.
LPi-1 effectively blocked Hippo signalling activity in HepG2 cells.
LPi-1 (10 mg/kg, i.p.) promotes the activation of YAP in vivo in in ICR mouse without any apparent side effects.
LPi-1 (3 mg/kg) promotes liver repair and regeneration in mice, ameliorates paracetamol (APAP)-induced liver injury.
LPi-1 provides protection against dextran sulphate sodium salt (DSS)-induced colitis in mice.

物理化学性质&存储条件

分子量 369.78
分子式 C19H13ClFN3O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(2-chloro-6-fluorobenzyl)-5-(1H-pyrrolo[2,3-b] pyridin-3-yl) furan-3-carboxamide

参考文献

1. Xiao C, et al. Br J Pharmacol. 2025 Jul 22. doi: 10.1111/bph.70137.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: